Peer-reviewed veterinary case report
Platelet and white blood cell changes in dogs with Babesia rossi
By Goddard, Amelia et al.·Published in Veterinary journal (London, England : 1997)·2015·Department of Companion Animal Clinical Studies·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Platelet activation and platelet-leukocyte interaction in dogs naturally infected with Babesia rossi.
- Species:
- dog
Plain-English summary
A group of 36 dogs infected with Babesia rossi, a parasite that can cause serious illness, were studied to see how their blood platelets interacted with other immune cells. The researchers found that the dogs that survived the infection had more activated immune cells compared to healthy dogs, suggesting a stronger immune response. Out of the 36 infected dogs, 29 survived while 7 did not. This study highlights the importance of monitoring blood cell activity in dogs with Babesia infections, as it may help predict outcomes and guide treatment.
People also search for: dog Babesia rossi infection symptoms · dog immune response to Babesia · how to treat Babesia in dogs
Abstract
Using flow cytometry, platelet-leukocyte aggregate (PLA) formation has previously been documented in dogs with a variety of systemic inflammatory disorders and immune-mediated haemolytic anaemia. Platelet activation and subsequent interaction between platelets and leukocytes are important for regulating innate immunity and systemic inflammation. The objective of this study was to investigate PLA formation in canine babesiosis and to determine whether it was associated with outcome. Blood was collected from 36 client-owned dogs diagnosed with Babesia rossi infection and 15 healthy controls using EDTA as anticoagulant. Activated platelets and PLA formation were detected by measuring surface expression of P-selectin (CD62P) on platelets, monocytes and neutrophils. Of the Babesia-infected dogs, 29 survived and seven died. The percentage of CD62P-positive monocytes was significantly higher (P = 0.036) in the Babesia-infected dogs (54%) than in healthy control dogs (35.3%). However, there were no significant differences between the Babesia-infected and control groups for CD62P-positive platelets (4.9% and 1.2%, respectively) and CD62P-positive neutrophils (28.3% and 17.9%, respectively). The percentage of CD62P-positive monocytes was significantly higher (P = 0.019) in the survivors (58.9%) than in healthy control dogs; however, there were no significant differences between the non-survivors (39.2%) and the controls or between survivors and non-survivors. There were no significant differences between groups for the percentage of CD62P-positive platelets (survivors 4.8%; non-survivors 5.3%; controls 1.2%) or CD62P-positive neutrophils (survivors 31.6%; non-survivors 5.6%; controls 17.9%). In conclusion, Babesia-infected dogs, specifically dogs that survived, had a significantly increased percentage of platelet-monocyte aggregates compared to healthy control dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/26088270/